Dorothy M. DeLisle
Pfizer (United States)(US)
Publications by Year
Research Areas
Viral Infections and Immunology Research, HIV Research and Treatment, RNA and protein synthesis mechanisms, HIV/AIDS drug development and treatment, Respiratory viral infections research
Most-Cited Works
- → Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes(1999)316 cited
- → Design, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C Protease(1996)145 cited
- → The respiratory burst oxidase of human neutrophils. Further studies of the purified enzyme.(1986)113 cited
- → Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 2. Peptide Structure−Activity Studies(1998)111 cited
- → Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure−Activity Studies(1998)92 cited
- → Substituted Benzamide Inhibitors of Human Rhinovirus 3C Protease: Structure-Based Design, Synthesis, and Biological Evaluation(2000)52 cited
- → Interaction of a Novel GDP Exchange Inhibitor with the Ras Protein(1998)48 cited
- → Design and Synthesis of Novel N-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors(2011)43 cited
- → Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK(2010)23 cited
- → A microtechnique for neutrophil respiratory burst oxidase in a cell-free system—characterization of oxidase activation system(1990)3 cited